| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 15, 2006
From the Vascular Physiology Unit, Institute of Child Health (S.P.L., R.W., A.T.P., A.D., J.E.D.), MRC Centre of Epidemiology for Child Health, Institute of Child Health (T.J.C.), Hatter Cardiovascular Institute and Centre for Cardiology (D.M.Y.), and Centre for Clinical Pharmacology and Therapeutics (S.P.L.), University College London; and Department of Cardiothoracic Surgery, UCL Hospitals NHS Foundation Trust (S.K.K.), London, United Kingdom. * To whom correspondence should be addressed. E-mail: s.loukogeorgakis{at}ich.ucl.ac.uk.
Background—Transient limb ischemia administered before a prolonged ischemic insult has systemic protective effects against ischemia-reperfusion (IR) injury (remote ischemic preconditioning [RIPC]). It has been demonstrated that protection from IR can be achieved by brief periods of ischemia applied at a remote site during an injurious ischemic event (remote postconditioning [RPostC]). Using an in vivo model of endothelial IR injury, we sought to determine whether RPostC occurred in humans and whether it shared mechanistic similarities with RIPC. Methods and Results—Endothelial function was assessed by flow-mediated dilation before and after IR (20 minutes of arm ischemia followed by reperfusion). RIPC was induced by conditioning cycles of 5 minutes of ischemia and reperfusion on the contralateral arm or leg before IR. For RPostC induction, conditioning cycles were administered during the ischemic phase of IR. Oral glibenclamide was used to determine the dependence of RIPC and RPostC on KATP channels. IR caused a significant reduction in flow-mediated dilation in healthy volunteers (baseline, 9.3±1.2% versus post-IR, 3.3±0.7%; P<0.0001) and patients with atherosclerosis (baseline, 5.5±0.6% versus post-IR, 2.3±0.5%; P<0.01). This reduction was prevented by RIPC (post-IR+RIPC: healthy volunteers, 7.2±0.5% [P<0.0001 versus post-IR]; patients, 4.5±0.3% [P<0.01 versus post-IR]) and RPostC (post-IR+RPostC: 8.0±0.5%; P<0.0001 versus post-IR). The protective effects of RIPC and RPostC were blocked by glibenclamide. Conclusions—This study demonstrates for the first time in humans that RPostC can be induced by transient limb ischemia and is as effective as RIPC in preventing endothelial IR injury. RIPC and RPostC share mechanistic similarities, with protection being dependent on KATP channel activation. These results suggest that remote conditioning stimuli could be protective in patients with acute ischemia about to undergo therapeutic reperfusion.
Accepted on July 5, 2007
Transient Limb Ischemia Induces Remote Preconditioning and Remote Postconditioning in Humans by a KATP Channel–Dependent Mechanism
Stavros P. Loukogeorgakis MBBS, BSc, PhD*,
Related Article:
Circulation 2007 116: 1337.
This article has been cited by other articles:
![]() |
H. L. Lujan and S. E. DiCarlo Partial Hindlimb Occlusion Reduced the Susceptibility to Sustained Ventricular Tachycardia in Conscious Rats Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2009; 14(3): 199 - 206. [Abstract] [PDF] |
||||
![]() |
S. P. Hoole, P. M. Heck, P. A. White, S. N. Khan, M. O'Sullivan, S. C. Clarke, and D. P. Dutka Remote Ischemic Preconditioning Stimulus Does Not Reduce Microvascular Resistance or Improve Myocardial Blood Flow in Patients Undergoing Elective Percutaneous Coronary Intervention Angiology, August 1, 2009; 60(4): 403 - 411. [Abstract] [PDF] |
||||
![]() |
S. P. Hoole, S. N. Khan, P. A. White, P. M. Heck, R. K. Kharbanda, C. G. Densem, S. C. Clarke, L. M. Shapiro, P. M. Schofield, M. O'Sullivan, et al. Remote ischaemic pre-conditioning does not attenuate ischaemic left ventricular dysfunction in humans Eur J Heart Fail, May 1, 2009; 11(5): 497 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Valen Extracardiac approaches to protecting the heart Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 651 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kloner Clinical Application of Remote Ischemic Preconditioning Circulation, February 17, 2009; 119(6): 776 - 778. [Full Text] [PDF] |
||||
![]() |
S. P. Hoole, P. M. Heck, L. Sharples, S. N. Khan, R. Duehmke, C. G. Densem, S. C. Clarke, L. M. Shapiro, P. M. Schofield, M. O'Sullivan, et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A Prospective, Randomized Control Trial Circulation, February 17, 2009; 119(6): 820 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Hausenloy and D. M. Yellon Remote ischaemic preconditioning: underlying mechanisms and clinical application Cardiovasc Res, August 1, 2008; 79(3): 377 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Downey and M. V. Cohen Bypassing Big Pharma Circulation, September 18, 2007; 116(12): 1344 - 1345. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |